K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Hagop M. Kantarjian
also known as H KANTARJIAN, H Kantarjian, H M Kantarjian
The University of Texas MD Anderson Cancer Center · Ontario Institute for Cancer Research · Goethe University Frankfurt · University of Hawaiʻi at Mānoa
About this author
Works
5,467
Cited by
265,121
h-index
231
i10
2490
ORCID ↗
Top papers
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Brian Druker, Moshe Talpaz, Debra Resta, et al.
·
2001
·
New England Journal of Medicine
↗ 5,231
OA
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury, Éric Solary, Oussama Abla, et al.
·
2022
·
Leukemia
↗ 3,753
OA
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Stephen G. O’Brien, François Guilhot, Richard A. Larson, et al.
·
2003
·
New England Journal of Medicine
↗ 3,557
OA
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Brian Druker, François Guilhot, Stephen G. O’Brien, et al.
·
2006
·
New England Journal of Medicine
↗ 3,470
OA
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg, Heinz Tuechler, Julie Schanz, et al.
·
2012
·
Blood
↗ 3,113
OA
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
Brian Druker, Charles L. Sawyers, Hagop M. Kantarjian, et al.
·
2001
·
New England Journal of Medicine
↗ 2,717
OA
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, et al.
·
2012
·
New England Journal of Medicine
↗ 2,030
OA
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat, et al.
·
2018
·
Blood
↗ 1,834
OA
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian, et al.
·
2006
·
New England Journal of Medicine
↗ 1,769
OA
A Tyrosine Kinase Created by Fusion of the <i>PDGFRA</i> and <i>FIP1L1</i> Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome
Jan Cools, Daniel J. DeAngelo, Jason Gotlib, et al.
·
2003
·
New England Journal of Medicine
↗ 1,694
OA
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Giuseppe Saglio, Dong‐Wook Kim, Surapol Issaragrisil, et al.
·
2010
·
New England Journal of Medicine
↗ 1,673
OA
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar, Kristen E. Stevenson, Omar Abdel‐Wahab, et al.
·
2011
·
New England Journal of Medicine
↗ 1,618